XML 43 R33.htm IDEA: XBRL DOCUMENT v3.25.2
Leases - Narrative (Details)
Jun. 30, 2025
USD ($)
Dec. 31, 2024
USD ($)
Jun. 30, 2024
Oct. 24, 2022
ft²
Nov. 15, 2021
ft²
renewalTerm
$ / ft²
Lessee, Lease, Description [Line Items]          
Rent increase         2.50%
Operating lease right-of-use assets $ 7,125,408 $ 6,176,923      
Weighted average remaining lease term 9 years 2 months 12 days   10 years    
Present value of remaining lease payments, percent 9.37% 9.38%      
Future minimum sublease income under noncancelable operating subleases $ 200,000        
Nephron Pharmaceuticals Corporation (“Nephron”)          
Lessee, Lease, Description [Line Items]          
Operating lease right-of-use assets 700,000        
Kindos          
Lessee, Lease, Description [Line Items]          
Operating lease right-of-use assets $ 1,400,000        
Wet Laboratory and Office Space          
Lessee, Lease, Description [Line Items]          
Leased area | ft²         16,903
Term of contract         157 months
Base rent per square foot | $ / ft²         33.06
Lessee, Operating Lease, Remaining Lease Term       5 years  
Square feet of office space | ft²       14,200  
Wet Laboratory and Office Space | Broadwest Lease, Five Year Renewal Option          
Lessee, Lease, Description [Line Items]          
Number of renewal terms | renewalTerm         2
Renewal term         5 years